Evolis

ASSA ABLOY, through its subsidiary, HID Global SAS, acquires 98.5% of Evolis in France and confirms the forthcoming filing of a public tender offer to acquire the remaining Evolis shares

Retrieved on: 
Wednesday, September 20, 2023

("Cedys") shares resulting in the indirect acquisition of approximately 84.4 percent (i.e.

Key Points: 
  • ("Cedys") shares resulting in the indirect acquisition of approximately 84.4 percent (i.e.
  • 4,407,707 shares) of the Evolis shares held by Cedys and the direct acquisition of 14.0 percent of Evolis shares from each of Crédit Mutuel Equity SCR and Crédit Mutuel Innovation (i.e.
  • The above transactions resulted in a combined purchase price paid of approximately EUR 224.9 million for 98.5 percent of the Evolis shares (i.e.
  • 5,140,349 shares), which is equivalent to a purchase price per Evolis share of EUR 43.75 (the "Acquisition").

ASSA ABLOY, through its subsidiary, HID Global SAS, acquires 98.5% of Evolis in France and confirms the forthcoming filing of a public tender offer to acquire the remaining Evolis shares

Retrieved on: 
Wednesday, September 20, 2023

("Cedys") shares resulting in the indirect acquisition of approximately 84.4 percent (i.e.

Key Points: 
  • ("Cedys") shares resulting in the indirect acquisition of approximately 84.4 percent (i.e.
  • 4,407,707 shares) of the Evolis shares held by Cedys and the direct acquisition of 14.0 percent of Evolis shares from each of Crédit Mutuel Equity SCR and Crédit Mutuel Innovation (i.e.
  • The above transactions resulted in a combined purchase price paid of approximately EUR 224.9 million for 98.5 percent of the Evolis shares (i.e.
  • 5,140,349 shares), which is equivalent to a purchase price per Evolis share of EUR 43.75 (the "Acquisition").

ASSA ABLOY intends to acquire Evolis in France

Retrieved on: 
Wednesday, July 19, 2023

("Cedys") for all of the Cedys' shares, noting that Cedys owns approximately 84.4 percent of the Evolis shares and voting rights (i.e.

Key Points: 
  • ("Cedys") for all of the Cedys' shares, noting that Cedys owns approximately 84.4 percent of the Evolis shares and voting rights (i.e.
  • 5,140,349 shares), which is equivalent to a purchase price per Evolis share of EUR 43.75 (the "Acquisition").
  • "I am looking forward to welcoming Evolis into the ASSA ABLOY Group.
  • Evolis would be a good technological addition to the ASSA ABLOY Group and would reinforce our current offering within the secure issuance business" says Nico Delvaux, President and CEO of ASSA ABLOY.

ASSA ABLOY intends to acquire Evolis in France

Retrieved on: 
Wednesday, July 19, 2023

("Cedys") for all of the Cedys' shares, noting that Cedys owns approximately 84.4 percent of the Evolis shares and voting rights (i.e.

Key Points: 
  • ("Cedys") for all of the Cedys' shares, noting that Cedys owns approximately 84.4 percent of the Evolis shares and voting rights (i.e.
  • 5,140,349 shares), which is equivalent to a purchase price per Evolis share of EUR 43.75 (the "Acquisition").
  • "I am looking forward to welcoming Evolis into the ASSA ABLOY Group.
  • Evolis would be a good technological addition to the ASSA ABLOY Group and would reinforce our current offering within the secure issuance business" says Nico Delvaux, President and CEO of ASSA ABLOY.

'All United for MG' organises first-ever European Myasthenia Gravis Day on June 2nd leads to pan-European call for action supported by European leaders

Retrieved on: 
Thursday, June 1, 2023

BRUSSELS, June 1, 2023 /PRNewswire/ -- The #AllUnitedforMG coalition, with the institutional support of argenx, brings together European patient associations and representatives from Belgium, France, Germany, Greece, Italy, Romania, Poland and Spain and aims to create awareness and gain recognition of this life-threatening disease, strengthen patients' rights for a better quality of life and obtain better patient care. The disease affects between 56.000 and 100.000 people in Europe 4.

Key Points: 
  • "Raising awareness about myasthenia gravis is not just about spreading knowledge, it's about empowering those who are living with it.
  • Our aim is to enhance patients' quality of life and reduce their mental burden," conclude the founders of the European Myasthenia Gravis Day.
  • "The first European Awareness Day for Myasthenia Gravis marks an important milestone towards increasing awareness and understanding of this rare disease.
  • Therefore we are very happy that there is finally a European Myasthenia Gravis Day to put a spotlight on this disease."

'All United for MG' organises first-ever European Myasthenia Gravis Day on June 2nd leads to pan-European call for action supported by European leaders

Retrieved on: 
Thursday, June 1, 2023

BRUSSELS, June 1, 2023 /PRNewswire/ -- The #AllUnitedforMG coalition, with the institutional support of argenx, brings together European patient associations and representatives from Belgium, France, Germany, Greece, Italy, Romania, Poland and Spain and aims to create awareness and gain recognition of this life-threatening disease, strengthen patients' rights for a better quality of life and obtain better patient care. The disease affects between 56.000 and 100.000 people in Europe 4.

Key Points: 
  • "Raising awareness about myasthenia gravis is not just about spreading knowledge, it's about empowering those who are living with it.
  • Our aim is to enhance patients' quality of life and reduce their mental burden," conclude the founders of the European Myasthenia Gravis Day.
  • "The first European Awareness Day for Myasthenia Gravis marks an important milestone towards increasing awareness and understanding of this rare disease.
  • Therefore we are very happy that there is finally a European Myasthenia Gravis Day to put a spotlight on this disease."